Prolonged exposure to topical cyclosporine A does not seem to promote conjunctival malignancy.
Böhringer
Daniel
D
Wojanowski
Bartosz
B
Reinhard
Thomas
T
D002471:Cell Transformation, Neoplastic; D003230:Conjunctival Neoplasms / Q000209:etiology* / Q000517:prevention & control*; D016572:Cyclosporine / Q000008:administration & dosage*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D009883:Ophthalmic Solutions
D007166:Immunosuppressive Agents; D009883:Ophthalmic Solutions; D016572:Cyclosporine